Sanbo Hospital Management Group Ltd
SZSE:301293
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (62.8), the stock would be worth ¥45.43 (32% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 92.8 | ¥67.15 |
0%
|
| 3-Year Average | 62.8 | ¥45.43 |
-32%
|
| 5-Year Average | 62.8 | ¥45.43 |
-32%
|
| Industry Average | 29.4 | ¥21.29 |
-68%
|
| Country Average | 28.9 | ¥20.92 |
-69%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
13.8B CNY | 92.8 | 164.5 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
98.7B USD | 11.5 | 14.5 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 40 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.8B ZAR | 9.4 | 14.2 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
78.2B MYR | 22.9 | 37.2 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.8B ZAR | -52.9 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
83.5B BRL | 9.1 | 17.9 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.7B USD | 6.8 | 11.2 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
97.1B CNY | 21.4 | 30.2 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 43.1 | 61.6 | |
| US |
|
Universal Health Services Inc
NYSE:UHS
|
10.6B USD | 7.3 | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 16.6 |
| Median | 28.9 |
| 70th Percentile | 52.9 |
| Max | 49 021 |
Other Multiples
Sanbo Hospital Management Group Ltd
Glance View
Sanbo Hospital Management Group Ltd., rooted in the bustling heart of China's healthcare sector, stands as a beacon of modern medical management and innovation. Founded with the mission to address the ever-growing healthcare demands of an expanding urban population, Sanbo has adeptly navigated the complexities of the industry through its impressive network of specialized hospitals and clinics. This enterprise thrives by streamlining hospital operations and fostering an environment where cutting-edge technologies meet compassionate care. By focusing primarily on neurology, a field with increasing incidence and demand globally, Sanbo captures a niche market. Its approach showcases a blend of expertise, employing skilled medical professionals coupled with state-of-the-art medical facilities, thereby enhancing the quality of patient outcomes and drawing a steady stream of clientele. The company's revenue engine hums efficiently by scaling its specialized services and implementing a multi-layered service model. Sanbo generates income through various channels, including direct patient care, diagnostic services, surgical treatments, and long-term patient management programs. Additionally, the firm harnesses strategic partnerships and collaborations with both public and private sectors to expand its reach and improve healthcare accessibility. A notable portion of its revenue also emanates from offering consultancy services to lesser-equipped hospitals looking to optimize their operations. By spearheading initiatives in research and development, Sanbo not only broadens its expertise but also attracts intellectual capital and investments. Each layer of its operations synergistically works to strengthen its foothold in the healthcare market, creating a sustainable model that continues to thrive amidst the evolving medical landscape.